Company: CI
Filing Date: 2025-02-27
Form Type: 10-K
Source: 0001739940-25-000009
Chunk: 622

Company: Cigna Group
Filing Date: 2025-02-27
Form: 10-K
Item: Item 7
Chunk 622
---
 1,166 1,155 TOTAL REVENUES247,121 195,265 180,518 Benefits and expensesPharmacy and other service costs182,509 133,801 124,834 Medical costs and other benefit expenses38,648 36,287 32,184 Selling, general and administrative expenses14,844 14,822 13,174 Amortization of acquired intangible assets1,703 1,819 1,876 TOTAL BENEFITS AND EXPENSES237,704 186,729 172,068 Income from operations9,417 8,536 8,450 Interest expense and other(1,435)(1,446)(1,228)Net gain (loss) on sale of businesses24 (1,499)1,662 Net investment losses(2,737)(78)(487)Income before income taxes5,269 5,513 8,397 TOTAL INCOME TAXES1,491 141 1,615 Net income3,778 5,372 6,782 Less: Net income attributable to noncontrolling interests344 208 78 SHAREHOLDERS' NET INCOME$3,434 $5,164 $6,704 Shareholders' net income per shareBasic$12.25 $17.57 $21.66 Diluted$12.12 $17.39 $21.41 

The accompanying Notes to the Consolidated Financial Statements are an integral part of these statements.

57

The Cigna GroupConsolidated Statements of Comprehensive IncomeFor the Years Ended December 31,(In millions)202420232022Net income$3,778 $5,372 $6,782 Other comprehensive income (loss), net of taxNet unrealized appreciation (depreciation) on securities and derivatives661 503 (1,598)Net long-duration insurance and contractholder liabilities measurement adjustments(1,067)(715)509 Net translation (losses) gains on foreign currencies(49)5 77 Postretirement benefits liability adjustment(22)1 420 Other comprehensive loss, net of tax(477)(206)(592)Total comprehensive income3,301 5,166 6,190 Comprehensive income (loss) attributable to noncontrolling interestsNet income attributable to redeemable noncontrolling interests— 180 11